Cargando…

Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease

BACKGROUND: Increased plasma level of lipoprotein(a) (Lpa) is a risk factor of cardiovascular diseases. This study aimed to explore the role of Lpa in the progression of atherosclerosis in patients with end-stage renal disease (ESRD) and to investigate whether its potential mechanism is mediated by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Kun Ling, Gong, Tie Kai, Hu, Ze Bo, Zhang, Yang, Wang, Gui Hua, Liu, Liang, Chen, Pei Pei, Lu, Jian, Lu, Chen Chen, Liu, Bi Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090984/ https://www.ncbi.nlm.nih.gov/pubmed/30071823 http://dx.doi.org/10.1186/s12882-018-0986-2

Ejemplares similares

Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease
por: Hu, Ze Bo, et al.
Publicado: (2016)

Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025
por: Sun, Ling, et al.
Publicado: (2016)

Apolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
por: Shim, Jeong, et al.
Publicado: (2017)

Probucol alleviates atherosclerosis and improves high density lipoprotein function
por: Zhong, Jian-Kai, et al.
Publicado: (2011)

The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis
por: Chang, Ching-Kun, et al.
Publicado: (2021)

Lower risk of end stage renal disease in diabetic nurse
por: Pan, Cheng-Chin, et al.
Publicado: (2017)

Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein
por: Kim, Hyun-Joo, et al.
Publicado: (2018)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Intimal hyperplasia induced by vascular intervention causes lipoprotein retention and accelerated atherosclerosis
por: Kijani, Siavash, et al.
Publicado: (2017)

Multimodality MRI Findings in Patients with End-Stage Renal Disease
por: Chen, Hui Juan, et al.
Publicado: (2015)

Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease †
por: Raikou, Vaia, et al.
Publicado: (2018)

The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy
por: Wang, Gui Hua, et al.
Publicado: (2019)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases
por: El-Senosy, Fatma M., et al.
Publicado: (2022)

HEART and TIMI Scores Predict Severe Coronary Atherosclerosis in Patients With End-Stage Renal Disease
por: Parikh, Trishna B, et al.
Publicado: (2023)

Potential injurious effects of the fine particulate PM2.5 on the progression of atherosclerosis in apoE-deficient mice by activating platelets and leukocytes
por: Zhu, Xuecan, et al.
Publicado: (2018)

Persistence of Lipoproteins and Cholesterol Alterations after Sepsis: Implication for Atherosclerosis Progression
por: Laudanski, Krzysztof
Publicado: (2021)

Decreased cerebral blood flow and improved cognitive function in patients with end-stage renal disease after peritoneal dialysis: An arterial spin-labelling study
por: Cheng, Ben-Chung, et al.
Publicado: (2018)

Immune Response to Lipoproteins in Atherosclerosis
por: Samson, Sonia, et al.
Publicado: (2012)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021)

Lipoprotein (a), Inflammation, and Atherosclerosis
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

Atherosclerosis Calcification: Focus on Lipoproteins
por: Neels, Jaap G., et al.
Publicado: (2023)

Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits
por: LI, CHEN, et al.
Publicado: (2015)

Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage 3
por: Lin, Yu-Hsuan, et al.
Publicado: (2017)

The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index
por: Coimbra, Susana, et al.
Publicado: (2019)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008)

Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
por: Zhang, Juan, et al.
Publicado: (2016)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease
por: Lu, Chung-Yen, et al.
Publicado: (2019)

Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
por: Zhu, Lin, et al.
Publicado: (2014)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
por: Lee, Chih-Kuo, et al.
Publicado: (2021)

The Importance of Lipoprotein Lipase Regulation in Atherosclerosis
por: Kumari, Anni, et al.
Publicado: (2021)

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Role of Podocyte Injury in Glomerulosclerosis
por: Lu, Chen-Chen, et al.
Publicado: (2019)

The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy
por: Lu, Yongzheng, et al.
Publicado: (2022)

Febuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report
por: Poh, Xue Er, et al.
Publicado: (2017)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l0shi8qk6a0o778n3hv9n3mmcv